ROIV
Roivant Sciences Ltd
NASDAQ · Biotechnology
$25.82
+4.68 (+22.14%)
Performance
1D
—
1W
+17.68%
1M
+16.52%
3M
+23.54%
6M
+115.89%
1Y
+139.30%
YTD
+17.74%
Open$24.48
Previous Close$21.14
Day High$25.95
Day Low$23.97
52W High$25.95
52W Low$8.73
Volume24.04M
Avg Volume6.80M
Market Cap17.96B
P/E Ratio—
EPS$-0.55
SectorBiotechnology
Volume Analysis
3.53x average volume
Technical Indicators
SMA 50
$21.97
Above
SMA 200
$15.70
Above
RSI (14)
67
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
19 analysts
Price Target
+211.5% upside
Current
$25.82
$25.82
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 27.89M | 34.56M | 2.78B |
| Net Income | -164,901,066 | -183,904,534 | -113,134,495 |
| Profit Margin | -592.0% | -562.4% | -4.1% |
| EBITDA | -940,652,435 | -1,107,335,580 | -200,438,119 |
| Free Cash Flow | — | — | -160,956,229 |
| Rev Growth | -19.3% | -19.3% | +17.6% |
| Debt/Equity | — | — | 0.59 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |